The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics
- PMID: 20832500
- PMCID: PMC2998584
- DOI: 10.1016/j.micinf.2010.08.012
The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics
Abstract
Myxoma virus (MYXV) is a poxvirus with a strict rabbit-specific host-tropism for pathogenesis. The immunoregulatory factors encoded by MYXV can suppress some functions of immune effectors from other species. We review their mechanisms of action, implications in therapeutics and the potential to improve MYXV as an oncolytic agent in humans.
Copyright © 2010 Institut Pasteur. Published by Elsevier SAS. All rights reserved.
References
-
- Stanford MM, Werden SJ, McFadden G. Myxoma virus in the European rabbit: interactions between the virus and its susceptible host. Vet Res. 2007;38:299–318. - PubMed
-
- Best SM, Collins SV, Kerr PJ. Coevolution of host and virus: cellular localization of virus in myxoma virus infection of resistant and susceptible European rabbits. Virology. 2000;277:76–91. - PubMed
-
- Jeklova E, Leva L, Matiasovic J, Kovarcik K, Kudlackova H, Nevorankova Z, Psikal I, Faldyna M. Characterisation of immunosuppression in rabbits after infection with myxoma virus. Vet Microbiol. 2008;129:117–130. - PubMed
-
- Barrett JW, Alston LR, Wang F, Stanford MM, Gilbert PA, Gao X, Jimenez J, Villeneuve D, Forsyth P, McFadden G. Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells. J Neurovirol. 2007;13:549–560. - PubMed
-
- Stanford MM, McFadden G. Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer. Expert Opin Biol Ther. 2007;7:1415–1425. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
